Antony Loebel
Signal active
Chief Medical Officer and President of Clinical Development
Contact Information
Social
Primary Organization
Sunovion Pharmaceuticals
Founded
1984
Employees
5001-10000
Industry
Biotechnology, Pharmaceutical, Therapeutics
Bio
Antony Loebel is the current Chief Medical Officer and President of Clinical Development of Seaport Therapeutics. He previously worked at Sunovion Pharmaceuticals as a President and CEO. Anthony attended the University of Washington School of Medicine.
Location
New York, New York, United States, North America
Jobs history
3
Seaport Therapeutics
Chief Medical Officer and President of Clinical Development
2024 - Current
Sunovion Pharmaceuticals
President and Chief Executive Officer
2019 - 2023
VP of Clinical Development
2007 - 2010
Educations
2
UW Medicine
Medicine
University of Washington
Profile Resume
Antony Loebel is the Chief Medical Officer and President of Clinical Development at Sunovion Pharmaceuticals, based in New York, New York, United States, North America. With a background in Biotechnology, Antony Loebel has a rich history of leadership and innovation.Antony Loebel studied Degree Medicine at UW Medicine. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.